EWTX
Price
$13.52
Change
-$0.21 (-1.53%)
Updated
Jul 18, 01:53 PM (EDT)
Capitalization
1.44B
20 days until earnings call
OPORF
Price
$0.24
Change
-$0.05 (-17.24%)
Updated
Feb 14 closing price
Capitalization
93.87M
Interact to see
Advertisement

EWTX vs OPORF

Header iconEWTX vs OPORF Comparison
Open Charts EWTX vs OPORFBanner chart's image
Edgewise Therapeutics
Price$13.52
Change-$0.21 (-1.53%)
Volume$300
Capitalization1.44B
OPEN ORPHAN
Price$0.24
Change-$0.05 (-17.24%)
Volume$3K
Capitalization93.87M
EWTX vs OPORF Comparison Chart in %
Loading...
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EWTX vs. OPORF commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Hold and OPORF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (EWTX: $13.73 vs. OPORF: $0.24)
Brand notoriety: EWTX and OPORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 49% vs. OPORF: 100%
Market capitalization -- EWTX: $1.44B vs. OPORF: $93.87M
EWTX [@Biotechnology] is valued at $1.44B. OPORF’s [@Biotechnology] market capitalization is $93.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileOPORF’s FA Score has 2 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • OPORF’s FA Score: 2 green, 3 red.
According to our system of comparison, OPORF is a better buy in the long-term than EWTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 5 TA indicator(s) are bullish.

  • EWTX’s TA Score: 5 bullish, 4 bearish.

Price Growth

EWTX (@Biotechnology) experienced а -1.01% price change this week, while OPORF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.33%. For the same industry, the average monthly price growth was +13.96%, and the average quarterly price growth was +35.38%.

Reported Earning Dates

EWTX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+3.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($1.44B) has a higher market cap than OPORF($93.9M). OPORF YTD gains are higher at: -34.871 vs. EWTX (-48.577). OPORF has higher annual earnings (EBITDA): 14M vs. EWTX (-167.72M). OPORF has higher revenues than EWTX: OPORF (56M) vs EWTX (0).
EWTXOPORFEWTX / OPORF
Capitalization1.44B93.9M1,538%
EBITDA-167.72M14M-1,198%
Gain YTD-48.577-34.871139%
P/E RatioN/A11.75-
Revenue056M-
Total Cash436MN/A-
Total Debt4.56MN/A-
TECHNICAL ANALYSIS
Technical Analysis
EWTXOPORF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
14%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACFOX73.79N/A
N/A
American Century Focused Dynamic Gr Inv
AGGIX12.63N/A
N/A
American Century Focused Global Gr I
WPGTX19.17N/A
N/A
WPG Partners Small Cap Value Div Fund
JNBCX10.09N/A
N/A
JPMorgan Income Builder C
NWZLX20.27N/A
N/A
Nationwide Loomis All Cap Gr A

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with VIR. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
+0.66%
VIR - EWTX
33%
Loosely correlated
+3.58%
AXON - EWTX
33%
Loosely correlated
+0.42%
CGON - EWTX
33%
Poorly correlated
+9.13%
SYRE - EWTX
32%
Poorly correlated
+4.26%
CRNX - EWTX
31%
Poorly correlated
+3.51%
More

OPORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with YMAB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then YMAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
YMAB - OPORF
34%
Loosely correlated
-0.69%
ENTX - OPORF
31%
Poorly correlated
N/A
PMN - OPORF
23%
Poorly correlated
+4.47%
EWTX - OPORF
6%
Poorly correlated
+0.66%
BCTX - OPORF
4%
Poorly correlated
+1.13%
More